Periodontal therapeutics are the non-surgical treatment for the periodontal diseases. Periodontal diseases are the infections of the structures around the teeth including the gums, the cementum that covers the root, the periodontal ligament and the aveolar bone.

The report titled “Global Periodontal therapeutics Market- Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall Periodontal therapeutics market along with the market size and estimates for the duration 2017 to 2025. The research study covers in-depth analysis of market segments based on therapeutic type and different geographical region.

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in global periodontal therapeutics market, attractive investment proposition and market positioning of key manufacturers sections.

Geographically, the global periodontal therapeutics market is studied for the following regional markets:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC
  • Rest of MEA

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global periodontal therapeutics market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global periodontal therapeutics market. This report concludes with company profiles section that highlights major information about the key players engaged in global periodontal therapeutics market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report. 

Thus, the research study provides a holistic view of the global periodontal therapeutics market, offering market size and estimates for the period from 2017 to 2025, keeping in mind the above-mentioned factors.

Based on the type of treatment, periodontal therapeutic the market is segmented into:

• Systemic AntibioticsDoxycycline
  
  • Minocycline
  • Metronidazole
  • Others
• Local Antibodies
  • Arestin
  • Chlorhexidine
  • Others

Periodontal diseases are the infections of the structures around the teeth including the gums, the cementum that covers the root, the periodontal ligament and the aveolar bone. In the initial stage of periodontal disease, gingivitis, the infection affects only the gums. In more severe forms of the disease, all of the supporting tissues are involved. Periodontal disease if untreated results in chronic inflammation leading to insulin resistance, reduced glucose tolerance and risk of diabetes. People with diabetes are at a higher risk of getting periodontitis than people without diabetes. According to World Health Organization (WHO) globally, an estimated 422 million adults were living with diabetes in 2014, and is expected to double till 2025, and a large number of diabetic people in the world will be in emerging economies such as India and China. Hence, the increasing prevalence of diabetes is driving the global periodontal therapeutics market. On the basis of treatment, the global periodontal therapeutics market has been segmented in terms of systemic antibiotics and local antibiotics. Systemic antibiotics held the largest share due to product affordability, availability and high market penetration would further drive the periodontal therapeutics market during the forecast period.

For the purpose of this study, the global periodontal therapeutics market is categorized as follows:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa 

For the purpose of this study, the global periodontal therapeutics market is segmented into regional markets viz., North America, Europe, Asia Pacific, Latin America, Middle East and Africa. In the base year 2016, North America dominated the global periodontal therapeutics market due to the higher awareness regarding periodontal diseases as compared to other regions. Moreover, prevalence of periodontal diseases due to sedentary lifestyle, efficient reimbursement scenario and rising geriatric population are the major driving factors for the rise in the periodontal therapeutics market in North America. Asia Pacific has emerged as the most lucrative market for periodontal therapeutics market due to large patient pool, growing healthcare infrastructure and expenditure.